Avalo Therapeutics, Inc.

AVTX · Healthcare · Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases…

Avalo Therapeutics, Inc. (AVTX), in the Healthcare sector, has 11 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 11 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 16 and filed Sep 18. The most active filer was Christopher Ryan Sullivan with 7 filings.

Add to watchlist

Filings, ttm

0 buys · 11 sells

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$7.7M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 16

Filed Sep 18

ADViAverage daily dollar volume

$28.3M

market data

Share price · 12M

$16.57 (+41.6%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $7.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Christopher Ryan Sullivan Chief Financial Officer 7 filings MD

Mittie Doyle Chief Medical Officer 2 filings JG

Jonathan Goldman Director 1 filing PV

Paul Varki Chief Legal Officer 1 filing

Recent filings

Christopher Ryan SullivanSALE Chief Financial Officer $202K
12,394 sh × $16.33
Exec Sep 16
Filed Sep 18 · 4:10 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $179K
10,185 sh × $17.62
Exec Sep 10
Filed Sep 11 · 4:10 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $1.4M
68,976 sh across 2 lots
Exec Aug 17
Filed Aug 19 · 4:10 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $449K
18,606 sh × $24.12
Exec May 7
Filed May 11 · 5:30 PM ET Mittie DoyleSALE Chief Medical Officer $2.1M
101,555 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $893K
44,300 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET Paul VarkiSALE Chief Legal Officer $1.5M
74,663 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $223K
16,915 sh across 2 lots
Exec Apr 29
Filed May 1 · 5:30 PM ET Christopher Ryan SullivanSALE Chief Financial Officer $231K
13,679 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET Mittie DoyleSALE Chief Medical Officer $412K
25,492 sh × $16.15
Exec Mar 16
Filed Mar 18 · 5:30 PM ET Jonathan GoldmanSALE Director $118K
8,200 sh × $14.35
Exec Nov 14 2025
Filed Nov 17 2025 · 5:30 PM ET